Exploring the Effectiveness of AI Generative Models for Diabetic Patients
1 other identifier
observational
300
1 country
1
Brief Summary
We plan to explore the usability of Generative AI-Chatbot for Diabetic Patient
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2023
CompletedFirst Submitted
Initial submission to the registry
March 9, 2023
CompletedFirst Posted
Study publicly available on registry
May 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedJune 5, 2023
June 1, 2023
2 years
March 9, 2023
June 2, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Usability of the Chatbot for diabetic patient
To assess the usability of the Chatbot, we will employ the mHealth App Usability Questionnaire (MAUQ) to gather feedback from patients following their interaction. Our study will utilize Table 4 of this questionnaire, which consists of three sections: ease of use, interface, and satisfaction and usefulness. Specifically, we will focus our evaluation on 10 out of the 18 questions presented in this table. The selected questions are S1, S2, S6, S7, S9, S11, S12, S13, S14, and S18. Patients will provide their responses on a scale of 1 to 5, where "1" indicates very poor and "5" denotes very good.
One time
Internet Speed
Minimum downloading speed of internet will be measured during the chat. This will be recorded in Mega bits per second.
One time
Secondary Outcomes (1)
Analyzing Chat response generated by AI Chatbot
One time
Study Arms (1)
Intervention
Patients will be provided access to Chatbot to enquire their querries regarding diabetic complications.
Interventions
All participants will be provided access to AI-Chatbot and will be asked to enquire their daily life problems related to diabetes. They will also be asked to review the replies of the Chatbot after their interaction.
Eligibility Criteria
People affected with diabetes in Pakistan
You may qualify if:
- Present physically in Pakistan
- Adults (18 years or older)
- Diabetic Patient
You may not qualify if:
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Prisoners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CDLE, PCSIR Lbas Complex
Karachi, Sindh, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ghulam Mustafa
Pakistan Council of Scientific and Industrial Research
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 9, 2023
First Posted
May 31, 2023
Study Start
January 5, 2023
Primary Completion
December 30, 2024
Study Completion (Estimated)
December 31, 2026
Last Updated
June 5, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will share